A drug once tested to treat the Ebola virus is showing promise in helping some Covid-19 patients recover quicker, according to US media reports.
Over 100 patients in the ongoing trial of experimental drug Remdesivir have severe symptoms. Nearly all of them have now been taken off ventilators or discharged from hospital after less than a week of treatment.
However, despite some success, two patients have died while on the drug.
The University of Chicago are warning that the data is incomplete, and that it's too soon to be drawing conclusions over the effectiveness of Remdesivir.
SHARE ME